Literature DB >> 8229659

Risk factors for HIV infection among injection drug users: results of blinded surveys in drug treatment centers, King County, Washington 1988-1991.

N V Harris1, H Thiede, J P McGough, D Gordon.   

Abstract

Among injection drug users (IDUs) entering drug treatment in King County, Washington between 1988 and 1991, we investigated HIV seroprevalence in relationship to demographic, sexual, and drug-use characteristics. Eighty-two of 3,039 (2.7%) IDUs tested HIV positive. Gay or bisexual men had the highest HIV prevalence (37.1%), followed by lesbian or bisexual women (8.3%), heterosexual men (2.3%), and heterosexual women (1.5%). American Indians were more likely to be infected with HIV than were whites. Those with no permanent address were more likely to be infected than those with an address. Unexpectedly, the prevalence of HIV infection among amphetamine injectors (13.1% of 168) was higher than among those who did not report using amphetamines. After adjustment for sexual orientation, HIV prevalence was four times higher among primary amphetamine injectors and three times higher among secondary amphetamine injectors than among injectors of other drugs. The basis for the strong association observed between HIV infection and a history of injection of amphetamines is not known and should be clarified through further research that obtains more detailed information on IDUs.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8229659

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr (1988)        ISSN: 0894-9255


  11 in total

1.  HIV prevalence, risk behaviors, and high-risk sexual and injection networks among young women injectors who have sex with women.

Authors:  Samuel R Friedman; Danielle C Ompad; Carey Maslow; Rebecca Young; Patricia Case; Sharon M Hudson; Theresa Diaz; Edward Morse; Susan Bailey; Don C Des Jarlais; Theresa Perlis; Amber Hollibaugh; Richard S Garfein
Journal:  Am J Public Health       Date:  2003-06       Impact factor: 9.308

2.  Glial reactivity in resistance to methamphetamine-induced neurotoxicity.

Authors:  Danielle M Friend; Kristen A Keefe
Journal:  J Neurochem       Date:  2013-03-17       Impact factor: 5.372

3.  Methamphetamine and HIV-1-induced neurotoxicity: role of trace amine associated receptor 1 cAMP signaling in astrocytes.

Authors:  Irma E Cisneros; Anuja Ghorpade
Journal:  Neuropharmacology       Date:  2014-06-17       Impact factor: 5.250

4.  Assessing differences in groups randomized by recruitment chain in a respondent-driven sample of Seattle-area injection drug users.

Authors:  Richard D Burt; Hanne Thiede
Journal:  Ann Epidemiol       Date:  2014-09-10       Impact factor: 3.797

5.  Longitudinal investigation of methamphetamine use among gay and bisexual men in New York City: findings from Project BUMPS.

Authors:  Perry N Halkitis; Kelly A Green; Paris Mourgues
Journal:  J Urban Health       Date:  2005-02-28       Impact factor: 3.671

6.  Methamphetamine enhances HIV infection of macrophages.

Authors:  Hao Liang; Xu Wang; Hui Chen; Li Song; Li Ye; Shi-Hong Wang; Yan-Jian Wang; Lin Zhou; Wen-Zhe Ho
Journal:  Am J Pathol       Date:  2008-05-05       Impact factor: 4.307

Review 7.  Biological treatments for amfetamine dependence : recent progress.

Authors:  Kevin P Hill; Mehmet Sofuoglu
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

8.  Prevalence of HTLV types I and II among drug users in King County, Washington.

Authors:  H Thiede; N V Harris; J P McGough; B Roberts; R F Khabbaz; J E Kaplan
Journal:  West J Med       Date:  1994-06

9.  Determinants of recent HIV infection among Seattle-area men who have sex with men.

Authors:  Hanne Thiede; Richard A Jenkins; James W Carey; Rebecca Hutcheson; Katherine K Thomas; Ronald D Stall; Edward White; Iris Allen; Roberto Mejia; Matthew R Golden
Journal:  Am J Public Health       Date:  2008-04-29       Impact factor: 9.308

10.  Evidence for risk reduction among amphetamine-injecting men who have sex with men; results from national HIV behavioral surveillance surveys in the Seattle area 2008-2012.

Authors:  Richard D Burt; Hanne Thiede
Journal:  AIDS Behav       Date:  2014-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.